Linked Data API

Show Search Form

Search Results

1128296
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, which countries his Department is engaging with in order to learn from their experiences in getting patients access to medical cannabis. more like this
star this property tabling member constituency Hemel Hempstead more like this
star this property tabling member printed
Sir Mike Penning more like this
star this property uin 257472 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>In developing its policy on cannabis-based products for medicinal use, the Government looked at approaches taken by other countries to learn from their experience. Broadly two approaches have been taken: to regulate as a medicine (both licenced and unlicensed) as in the United Kingdom or to regulate outside of the medicinal regime as in Canada. In reviewing the available international evidence, the Chief Medical Officer for England and Chief Medical Adviser to the UK Government, looked at evidence reviews from the United States, Ireland, Australia, and the World Health Organization. Departmental officials have also reviewed information from a wide range of other countries and have spoken to the authorities and organisations in Australia, Canada, Denmark, the Netherlands, and the United States (New York).</p> more like this
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 257473 more like this
star this property question first answered
less than 2019-06-10T13:28:33.413Zmore like thismore than 2019-06-10T13:28:33.413Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1528
unstar this property label Biography information for Sir Mike Penning more like this
1128297
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what evidence his Department has reviewed from other countries on the effectiveness of cannabis as a medicine. more like this
star this property tabling member constituency Hemel Hempstead more like this
star this property tabling member printed
Sir Mike Penning more like this
star this property uin 257473 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>In developing its policy on cannabis-based products for medicinal use, the Government looked at approaches taken by other countries to learn from their experience. Broadly two approaches have been taken: to regulate as a medicine (both licenced and unlicensed) as in the United Kingdom or to regulate outside of the medicinal regime as in Canada. In reviewing the available international evidence, the Chief Medical Officer for England and Chief Medical Adviser to the UK Government, looked at evidence reviews from the United States, Ireland, Australia, and the World Health Organization. Departmental officials have also reviewed information from a wide range of other countries and have spoken to the authorities and organisations in Australia, Canada, Denmark, the Netherlands, and the United States (New York).</p> more like this
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 257472 more like this
star this property question first answered
less than 2019-06-10T13:28:33.447Zmore like thismore than 2019-06-10T13:28:33.447Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1528
unstar this property label Biography information for Sir Mike Penning more like this
1128299
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care on 20 May 2019, Official Report, column, 571, what plans he has to include observational trials in building up the existing evidence-base. more like this
star this property tabling member constituency Hemel Hempstead more like this
star this property tabling member printed
Sir Mike Penning more like this
star this property uin 257475 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>In all areas of scientific research, a range of evidence builds our understanding. This includes individual cases and observational trials. It is the promise shown from these observational studies and experience, from all around the world, that provides the basis for public funding of further research into the use of cannabis based products as medicines through the National Institute for Health Research. This further clinical research will provide a greater level of understanding of cannabis-based medicines, how to use them to best effect, who may benefit and under what circumstances, how cannabis interacts with other medications and define further any contraindications. It is this level of research outcomes that will provide confidence to prescribers and the information necessary to make routine funding decisions within the National Health Service.</p><p>The existing experience, studies and research in this area will be used by the National Institute for Health and Care Excellence to develop their clinical guidelines due to be published later this year.</p>
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-10T13:26:43.077Zmore like thismore than 2019-06-10T13:26:43.077Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1528
unstar this property label Biography information for Sir Mike Penning more like this
1128300
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the cost-effectiveness of patients receiving an NHS prescription for wholeplant medical cannabis. more like this
star this property tabling member constituency Hemel Hempstead more like this
star this property tabling member printed
Sir Mike Penning more like this
star this property uin 257476 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</p><p>In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</p><p><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></p>
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 257706 more like this
star this property question first answered
less than 2019-06-10T13:18:03.323Zmore like thismore than 2019-06-10T13:18:03.323Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1528
unstar this property label Biography information for Sir Mike Penning more like this
1128309
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Social Prescribing more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if his Department will work with NHS England to add measures of loneliness to the NHS England Outcomes Framework for social prescribing. more like this
star this property tabling member constituency Croydon North more like this
star this property tabling member printed
Mr Steve Reed more like this
star this property uin 257558 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>As social prescribing is locally driven, different approaches to evaluation and the measurement of outcomes have emerged across England. To encourage consistent data gathering and reporting of outcomes, NHS England has worked with a wide range of stakeholders to develop a Common Outcomes Framework for measuring the impact of social prescribing. Working with a wide range of stakeholders, a consensus has been built for all social prescribing connector schemes to measure a number of outcomes, including impact on the person. This includes how a person’s wellbeing has improved, whether they are less lonely and whether they feel more in control and have a better quality of life.</p><p> </p><p>More information on the Common Outcomes Framework can be found in ‘Social prescribing and community-based support Summary guide’, published by NHS England in January 2019 which is available at the following link:</p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2019/01/social-prescribing-community-based-support-summary-guide.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2019/01/social-prescribing-community-based-support-summary-guide.pdf</a></p>
star this property answering member constituency Gosport more like this
unstar this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-06-10T15:15:17.657Zmore like thismore than 2019-06-10T15:15:17.657Z
unstar this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
unstar this property tabling member
4268
unstar this property label Biography information for Mr Steve Reed more like this
1128355
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Mental Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will increase resources for (a) emotional and (b) mental health support for people living with diabetes. more like this
star this property tabling member constituency Knowsley more like this
star this property tabling member printed
Mr George Howarth more like this
star this property uin 257485 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>The NHS Long Term Plan committed to increasing the provision of mental health support for all patients who require it. The importance of addressing the mental health needs of people with diabetes is recognised and further work is underway to consider the most effective routes for supporting this as part of the future development of services.</p><p> </p><p>On 21 March 2018, NHS England and NHS Improvement, along with the National Collaborating Centre for Mental Health, published ‘The Improving Access to Psychotherapy Therapy (IAPT) Pathway for People with Long-term Physical Health Conditions and Medically Unexplained Symptoms.’ The guidance outlines the IAPT pathway, and accompanying benchmarks, to support the national expansion of IAPT services for adults with long term conditions and medically unexplained symptoms.</p><p> </p><p>In addition, a project working group has been established involving NHS England, Diabetes UK and other stakeholders which aims to develop a care pathway which, when adopted locally, would help improve access to emotional and psychological support for people with diabetes.</p><p> </p>
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-10T13:13:40.637Zmore like thismore than 2019-06-10T13:13:40.637Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
481
unstar this property label Biography information for Sir George Howarth more like this
1128357
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Mental Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if his Department will request the National Institute for Health and Care Excellence to amend its guidance on Type 1 and Type 2 diabetes to include the identification of emotional and psychological support needs in all diabetes care. more like this
star this property tabling member constituency Knowsley more like this
star this property tabling member printed
Mr George Howarth more like this
star this property uin 257487 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>As an independent body, following the referral of a guideline topic by NHS England or Ministers, the National Institute for Health and Care Excellence (NICE) develops the scope of its guidelines in consultation with stakeholders.</p><p>NICE’s published guidelines on the management of type 1 diabetes in children and adults include recommendations on emotional and psychological support. This guidance is available on the NICE website.</p> more like this
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-10T13:30:16.02Zmore like thismore than 2019-06-10T13:30:16.02Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
481
unstar this property label Biography information for Sir George Howarth more like this
1128377
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Prostate Cancer: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage men to get tested for prostate cancer. more like this
star this property tabling member constituency Upper Bann more like this
star this property tabling member printed
David Simpson more like this
star this property uin 257491 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>There are risks and benefits ‎of testing for prostate cancer. There are side effects to many of the treatments for prostate cancer, such as impotence and incontinence, but, there is no doubt that, in some cases, if found early, ‎it could save lives. However, many of the men having tests and receiving treatment would not have any symptoms or problems relating to their cancers in their life.</p><p>The Prostate Cancer Risk Management Programme (PCRMP) supports men in making an informed choice on whether to be tested for prostate cancer. The PCRMP provides general practitioners and primary care professionals with information to counsel asymptomatic men aged 50 and over who ask about prostate specific antigen testing for prostate cancer.</p><p>Further information on the PCRMP is available at the following link:</p><p><a href="https://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview" target="_blank">https://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview</a></p>
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-10T13:16:14.42Zmore like thismore than 2019-06-10T13:16:14.42Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1597
unstar this property label Biography information for David Simpson more like this
1128378
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Dental Services: Finance more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how much Government funding was allocated to NHS orthodontist services in each of the last three years. more like this
star this property tabling member constituency Upper Bann more like this
star this property tabling member printed
David Simpson more like this
star this property uin 257492 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>Information on funding allocations for National Health Service orthodontist services is not available. NHS England is responsible for determining funding allocations for NHS dentistry. These allocations are included in the primary care allocations made to NHS regional teams. However, NHS England does not allocate funding specifically for NHS orthodontics. Data on NHS orthodontics expenditure is not held centrally.</p> more like this
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-10T13:14:46.74Zmore like thismore than 2019-06-10T13:14:46.74Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
1597
unstar this property label Biography information for David Simpson more like this
1128389
star this property registered interest false more like this
star this property date less than 2019-05-22more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Allergies: Medical Equipment more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the availability of epinephrine auto injectors for children in (a) Wakefield and (b) England. more like this
star this property tabling member constituency Morley and Outwood more like this
star this property tabling member printed
Andrea Jenkyns more like this
star this property uin 257594 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>Supplies of all paediatric epinephrine auto-injectors are currently available in volumes that are sufficient to meet normal United Kingdom demand. The Department does not hold information about the volume available in Wakefield. All patients who require an epinephrine (adrenaline) auto-injector should now be able to obtain a device from their pharmacy. The Department continues to work very closely with all the manufacturers of epinephrine auto-injectors and can confirm that the supply situation continues to improve.</p> more like this
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-10T13:32:17.58Zmore like thismore than 2019-06-10T13:32:17.58Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
unstar this property tabling member
4490
unstar this property label Biography information for Andrea Jenkyns more like this